Fennec Pharma appoints new CMO, CCO, CSO to accelerate growth

FENNEC PHARMACEUTICALS INC.

Pierre Sayad appointed CMO, Terry Evans CCO, Christiana Cioffi CSO, effective Oct. 28, 2024.
Sayad receives $450,000 base salary and 150,000 options; Evans $400,000 + 150,000 options.
Cioffi receives $375,000 base salary and 150,000 options; each eligible for 40% target bonus.
All three executives have extensive oncology and rare disease launch experience.
Appointments aim to boost commercialization of PEDMARK for cisplatin-induced ototoxicity.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Appointed

Christiana Cioffi

Chief Strategy Officer

FENC · FENNEC PHARMACEUTICALS INC.

Effective: 2024-10-28
Filed: October 30, 2024, 7:59 PM ET

Ms. Christiana Cioffi, MBA, as Chief Strategy Officer ("CSO"),

Appointed

Pierre S. Sayad

Chief Medical Officer

FENC · FENNEC PHARMACEUTICALS INC.

Effective: 2024-10-28
Filed: October 30, 2024, 7:59 PM ET

On October 28, 2024, Fennec Pharmaceuticals Inc.'s (the "Company") announced the appointments of Mr. Pierre S. Sayad, PhD, M.S., as Chief Medical Officer ("CMO"),

Appointed

Terry Evans

Chief Commercial Officer

FENC · FENNEC PHARMACEUTICALS INC.

Effective: 2024-10-28
Filed: October 30, 2024, 7:59 PM ET

Mr. Terry Evans as Chief Commercial Officer ("CCO"),

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Christiana Cioffi was appointed as Chief Strategy Officer at FENNEC PHARMACEUTICALS INC..

Action: appointed
Role: Chief Strategy Officer

Exact text from the filing

Ms. Christiana Cioffi, MBA, as Chief Strategy Officer ("CSO"),

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Pierre S. Sayad was appointed as Chief Medical Officer at FENNEC PHARMACEUTICALS INC..

Action: appointed
Role: Chief Medical Officer

Exact text from the filing

On October 28, 2024, Fennec Pharmaceuticals Inc.'s (the "Company") announced the appointments of Mr. Pierre S. Sayad, PhD, M.S., as Chief Medical Officer ("CMO"),

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Terry Evans was appointed as Chief Commercial Officer at FENNEC PHARMACEUTICALS INC..

Action: appointed
Role: Chief Commercial Officer

Exact text from the filing

Mr. Terry Evans as Chief Commercial Officer ("CCO"),

View on SEC.gov

FENNEC PHARMACEUTICALS INC. filing history →

Source: SEC EDGAR

accession 0001104659-24-112405

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.